Financial Statements — FRVO
Balance Sheet
(in billions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Cash & Equivalents | 2.11 | 0.28 |
| Total Current Assets | 2.15 | 0.31 |
| Total Non-current Assets* | 1.38 | 1.12 |
| Total Assets | 3.54 | 1.43 |
| Total Current Liabilities | 0.25 | 0.20 |
| Long-term Debt | 0.22 | 0.19 |
| Total Non-current Liabilities* | 0.30 | 0.30 |
| Total Liabilities | 0.55 | 0.50 |
| Retained Earnings | (0.33) | (0.28) |
| Total Stockholder Equity | 2.79 | (0.28) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 |
|---|
| Total Revenue | 0.11 | 0.06 |
| Cost of Revenue | 0.31 | 0.48 |
| Gross Profit | (0.19) | (0.42) |
| Selling, General & Admin | 27.43 | 16.99 |
| Total Operating Expenses | 28.55 | 19.63 |
| Operating Income | (28.74) | (20.05) |
| Pretax Income | (55.91) | (31.83) |
| Tax Provision | 0.00 | -- |
| Net Income | (55.91) | (31.83) |
| Basic EPS | (0.38) | (3.72) |
| Diluted EPS | (0.38) | (3.72) |
Cash Flow Statement
(in billions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Operating Cash Flow | (0.03) | (0.01) |
| Capital Expenditures | 0.23 | 0.17 |
| Free Cash Flow* | (0.26) | (0.18) |
| Investing Cash Flow | (0.23) | (0.17) |
| Financing Cash Flow | 2.09 | 0.00 |
* Derived from reported values
